All In MedTech

Device Trial Radar · NCT07021742

BioHealx® Anal Fistula Device Post Market Surveillance Study

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Jun 14, 2025

Primary completion

Feb 2027

Study completion Mar 2027

Sponsor

Lead sponsor
Signum Surgical USA Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 15, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post market surveillance study is a single arm multicenter study to demonstrate the long-term durability and effectiveness of the BioHealx Anal Fistula Device for fistula-in-ano closure (internal and external fistula openings).

Conditions

  • Fistula-in-ano

Interventions

  • BioHealxDevice

    Subjects will have their anal fistula treated with the BioHealx Anal Fistula Device, a bioabsorbable implant designed to securely close the fistula internal opening, preventing reinfection, while allowing for drainage through the external opening during healing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful Closure RepairTime frame: 12 Months
  2. Non-Recurrence IncidenceTime frame: 24 and 36 Months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • The Colorectal Institute

    Fort Myers, Florida · Recruiting

  • Hackensack University Medical Center

    Hackensack, New Jersey · Recruiting

  • Weill Cornell Medicine

    New York, New York · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.